Patent details

Basic Information

Publication number:

EP1765397

PCT Application Number:

PCT/US/2005/018322

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057542193

PCT Publication Number:

WO/2005/116077

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Inhibitory antibodies binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR)

French Title of Invention:

Anticorps inhibitants se liant au complex de l'activateur du plasminogene de type urokinase (uPA) et son recepteur (uPAR)

German Title of Invention:

Hemmende Antikörper, die den Komplex aus urokinaseartigem Plasminogenaktivator (uPA) und dessen Rezeptor (uPAR) binden

SPC Number:

Dates

Filing date:

25/05/2005

Grant date:

24/10/2012

EP Publication Date:

24/10/2012

PCT Publication Date:

08/12/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/03/2007

EP B1 Publication Date:

24/10/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/05/2024

Expiration date:

25/05/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/05/2005

 

 

Name:

Tactic Pharma LLC

Address:

1007 Church Street, Suite 307, Evanston 60201, United States (US)

Inventor

1

Name:

PARRY Graham, C.

Address:

United States (US)

2

Name:

MAZAR Andrew P.

Address:

United States (US)

Priority

Priority Number:

573896 P

Priority Date:

25/05/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

19/05/2023

Last Annual Fee Paid Number:

19

Last Annual Fee Paid Amount:

281 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages